EGFR-TKI

A Prospective Multicenter Study of the Association Between TCM Syndromes and EGFR-TKI Efficacy in Lung Cancer Patients

Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer

Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1

Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC

Efficacy of Targeted Therapy Combined Chemotherapy in Advanced EGFR Positive NSCLC Patients

Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC

EGFR-TKI Concurrent With/Without WBRT in Brain Metastasis From NSCLC

EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism

EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism

Efficacy Study of Chinese Medicine Plus EGFR-TKI Versus EGFR-TKI in Advanced Pulmonary Adenocarcinoma

A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy

Study of EGFR-TKI to Asymptomatic Brain Metastases of NSCLC